Novel derivatives of 9-β-d-arabinofuranosylpurines that are cytotoxic to variants of human leukemia lymphoblast cells resistant to both 1-β-D-arabinofuranosylcytosine and 9-β-d-arabinopuranosyladenine

This publication has 9 references indexed in Scilit:

• 2'-O-Nitro-1-.beta.-D-arabinofuranosylcytosine. A new derivative of 1-.beta.-D-arabinofuranosylcytosine that resists enzymic deamination and has antileukemic activity
  Journal of Medicinal Chemistry, 1983
• Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice
  Biochemical Pharmacology, 1982
• Isolation and preliminary characterization of 9-β-d-arabinofuranosyladenine-resistant mutants of baby hamster cells
  Somatic Cell and Molecular Genetics, 1982
• Comparative effects of the 5′-triphosphates of 9-β-(2′azido-2′-deoxy-D-arabinofuranosyl)adenine and 9-β-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells
  Nucleic Acids Research, 1982
• Deoxycoformycin: Neurological toxicity
  Cancer Chemotherapy and Pharmacology, 1981
• Cytotoxic activity of the adenine arabinoside analogs, 2′-azido- and 2′-amino-2′-deoxy-β-D-arabinofuranosyladenine
  Biochemical Pharmacology, 1979
• Potent inhibition of muscle 5′-AMP deaminase by the nucleoside antibiotics coformycin and deoxycoformycin
  Biochemical Pharmacology, 1977
• 5-azacytidine and arabinosyl adenine for the treatment of acute leukemia
  Leukemia Research, 1977
• Alterations in enzyme activity in tumors and the implications for chemotherapy
  Advances in Enzyme Regulation, 1970